Evaluation on the preparation and performance of lysine modified polylactic acid nanofiber stent

doi:10.12307/2022.257

Abstract

Abstract: BACKGROUND: Polylactic acid as a biodegradable polymer has been made into nanofiber stent, widely used in tissue regeneration. However, as a scaffold material, polylactic acid has some limitations, such as slow degradation rate and poor biocompatibility.
OBJECTIVE: To prepare lysine-polylactic acid stents to study the structure and properties of stents by controlling different lysine concentrations.
METHODS: With 1, 4-dioxane as solvent system and lysine as an ammonia solution, thermally induced phase separation technology was used to prepare the lysine-polylactic acid stents. Lysine concentrations were 5%, 10%, 15%, 30%, respectively. The detection of Fourier transform infrared spectrometer, scanning electron microscope, differential scanner thermal analyzer, contact angle and mechanical performance analysis were carried out with the unaltered polylactic acid bracket as the control.
RESULTS AND CONCLUSION: (1) Fourier transform infrared spectral analysis showed that the polylactic acid stent was successfully modified by lysine ammonia. (2) The scanning electron microscope showed that when the non-solvent phase was deuterium depleted water, the fiber mesh structure of the bracket was poor and no three-dimensional structure was formed. When the concentration of lysine was 5%, the stent was flaky, ribbon or a large number of reunion phenomenon, and no good three-dimensional fiber network structure was formed. With the increase of lysine concentration, the nanofiber structure of the stent gradually formed. When the concentration of lysine was 10%, the prepared stent still had flaky and reunion phenomenon. When the concentration of lysine was 15%, the stent had a relatively uniform distribution of nanofiber structure. However, when the concentration of lysine was 30%, the structure of stent fiber collapsed and large areas reunited. (3) With the increase of lysine concentration, the water contact angle of the stent was reduced and the strength of pressure was reduced. (4) With the increase of lysine concentration, the melting temperature of the stent decreased slightly, but there was no obvious change, and the crystallization increased. (5) The results show that the introduction of lysine improves the mesh fiber structure, hydrophobicity and crystallization of polylactic acid stent and reduces the mechanical properties of the bracket.

Key words: polylactic acid, nanofiber, stent, lysine, thermal induced phase separation technology, tissue engineering

CLC Number:

Li Yu, Pan Yuancheng, Lin Ran, Chen Shunyou. Evaluation on the preparation and performance of lysine modified polylactic acid nanofiber stent[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(16): 2557-2561.

Figures/Tables 6

References

[1] MA H, HU J, MA PX. Polymer scaffolds for small-diameter vascular tissue engineering. Adv Funct Mater. 2010;20(17):2833-2841.
[2] HU J, SUN X, MA H, et al. Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials. 2010;31(31):7971-7977.
[3] HU J, FENG K, LIU X, et al. Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials. 2009; 30(28):5061-5067.
[4] STEVENS MM. Biomaterials for bone tissue engineering. Mater Today. 2008;11(5):18-25.
[5] ESTHER JL, KASPER FK, ANTONIOS GM. Biomaterials for tissue engineering. Ann Biomed Eng. 2014;42(2):323-337.
[6] MARK W, NICHOLAS JC. Long-term in vivo degradation of poly-L-lactide (PLLA) in bone. J Biomater Appl. 2007;21(4):395-411.
[7] CHEN VJ, MA PX. The effect of surface area on the degradation rate of nano-fibrous poly(L-lactic acid) foams. Biomaterials. 2006;27(20): 3708-3715.
[8] LIU XH, MA PX. The nanofibrous architecture of poly(L-lactic acid)-based functional copolymers. Biomaterials. 2010;31(2):259-269.
[9] LANGER R, VACANTI JP. Tissue engineering. Science. 1993;260(5110): 920-926.
[10] MA PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;60(2):184-198.
[11] HENCH, LARRY L, POTAK, et al. Third-generation biomedical materials. Science. 2002;295(5557):1014-1017.
[12] LIU X, MA PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng. 2004;32(3):9622-9629.
[13] LI J, CHEN Y, MAK AT, et al. A one-step method to fabricate PLLA scaffolds with deposition of bioactive hydroxyapatite and collagen using ice-based microporogens. Acta Biomater. 2010;6(6):2013-2019.
[14] SHIN H, JO S, MIKOS AG. Biomimetic materials for tissue engineering. Biomaterials. 2003;24(24):4353-4364.
[15] WEI G, MA PX. Nanostructured biomaterials for regeneration. Adv Funct Mater. 2010;18(22):3568-3582.
[16] WOO KM, CHEN VJ, MA PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A. 2003;67(2):531-537.
[17] WOO KM, JUN JH, CHEN VJ, et al. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials. 2007; 28(2):335-343.
[18] HU J, LIU X, MA PX. Induction of osteoblast differentiation phenotype on poly(L-lactic acid) nanofibrous matrix. Biomaterials. 2008;29(28): 3815-3821.
[19] EPPLEY BL, REILLY M. Degradation characteristics of PLLA-PGA bone fixation devices. J Craniofac Surg. 1997;8(2):116-120.
[20] QUIRK RA, CHAN WC, DAVIES MC, et al. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials. 2001; 22(8):865-872.
[21] NIU X, LI X, LIU H, et al. Homogeneous chitosan/poly(L-lactide) composite scaffolds prepared by emulsion freeze-drying. J Biomater Sci Polym Ed. 2012;23(1-4):391-404.
[22] KALIVA M, GEORGOPOULOU A, DRAGATOGIANNIS DA, et al. Biodegradable Chitosan-graft-Poly(l-lactide) copolymers for bone tissue engineering. Polymers (Basel). 2020;12(2):316.
[23] 王雪红,陈智,魏杰,等.赖氨酸改性聚乳酸/聚乙二醇共聚物的制备及表征[J].高分子材料科学与工程,2016,32(9):1-6.
[24] WU JZ, ZHAO JJ, ZHANG B, et al. Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Int J Nanomedicine. 2013;9(1):5261-5271.
[25] 周炳华,廖文波.改性聚乳酸-羟基乙酸/Ⅰ型胶原复合支架的细胞亲和性[J].中国组织工程研究与临床康复,2009,13(29):5687-5690.
[26] LI WJ, TULI R, HUANG X, et al. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials. 2005;26(25):5158-5166.
[27] MA Z, HE W, YONG T, et al. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation. Tissue Eng. 2005;11(7): 1149-1158.
[28] YOSHIMOTO H, SHIN YM, TERAI H, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003;24(12):2077-2082.
[29] LIU X, SMITH L, WEI G, et al. Surface engineering of Nano-Fibrous Poly(L-Lactic acid) scaffolds via Self-Assembly technique for bone tissue engineering. J Biomed Nanotechnol. 2005;1(1):54-60.
[30] SHAO J, CHEN C, WANG Y, et al. Early stage structural evolution of PLLA porous scaffolds in thermally induced phase separation process and the corresponding biodegradability and biological property. Polym Degrad Stabil.2012;97(6):955-999.